OncoMed Pharmaceuticals, Inc. To Present Data On Anti-Cancer Stem Cell Candidates At The American Association for Cancer Research Meeting
Published: Mar 06, 2014
REDWOOD CITY, Calif., March 6, 2014 (GLOBE NEWSWIRE) -- OncoMed Pharmaceuticals Inc. (Nasdaq:OMED), a clinical-stage company developing novel therapeutics that target cancer stem cells (CSCs), or tumor-initiating cells, today announced that it will provide an extensive update on its anti-cancer stem cell pipeline at the upcoming American Association of Cancer Research (AACR) meeting to be held April 5-9, 2014 in at the San Diego Convention Center in San Diego, CA.
Help employers find you! Check out all the jobs and post your resume.